GlassScriptPhysician profile
Chong C Lee
NPI 1497855647
$23,518.46
in general payments reported to CMS, 2019-2025
31 companies · $288 in 2025
The $288 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $57.14 · 2021: $525 · 2022: $350 · 2023: $923 · 2024: $21K · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $19K · Travel and Lodging: $1,608 · Food and Beverage: $1,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $19,321.68 |
| Travel and Lodging | $1,608.24 |
| Food and Beverage | $1,336.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,274.75 | 2021-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $574.44 | 2021-2025 | Corevalve Evolut R, Avalus, Venaseal |
| Edwards Lifesciences Corporation | $210.43 | 2020-2025 | Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $168.72 | 2019-2022 | |
| Atricure, INC. | $163.27 | 2019-2024 | |
| Medtronic Vascular, INC. | $136.60 | 2019 | |
| Getinge USA Sales, LLC | $128.66 | 2021 | |
| Boston Scientific Corporation | $91.37 | 2022-2024 | Eluvia, Angiojet Ultra 5000a |
| Abiomed | $75.03 | 2021-2023 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $72.69 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $68.74 | 2020-2021 | |
| Pfizer INC. | $53.09 | 2022 | |
| Silk Road Medical, INC. | $52.48 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Merck Sharp & Dohme LLC | $51.08 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.04 | 2019-2025 | Jardiance |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $36.03 | 2023 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Abbott Laboratories | $35.99 | 2024 | Jot Dx, Xact |
| Kls-Martin L.P. | $33.76 | 2021 | |
| W. L. Gore & Associates, INC. | $31.31 | 2025 | Gore Excluder Aaa Endoprosthesis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.11 | 2019 | |
| Veran Medical Technologies, INC. | $23.09 | 2019-2020 | |
| Urgo Medical North America, LLC | $22.48 | 2023 | Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Amarin Pharma, INC. | $20.78 | 2021 | |
| Organogenesis INC. | $19.96 | 2023 | Puraply |
| Chiesi USA, INC. | $16.91 | 2021 | |
| Olympus America INC. | $16.33 | 2021 | |
| Tactile Systems Technology INC | $16.29 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.68 | 2024 | Farxiga |
| Amgen INC. | $14.06 | 2021 | |
| La Jolla Pharmaceutical Company | $13.59 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.70 | 2023 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chong Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.